Conference Coverage: EHA 2024 – Focus on NHL and CLL

Lymphoma-specific discussions on the latest research updates, therapeutic advances, and their application in clinical decision-making

June 26, 2024


Jason Westin, MD

University of Texas MD Anderson Cancer Center, Houston, TX, USA

Faculty Members

John Allan, MD
Weill Cornell Medicine, New York, NY

Joseph M. Tuscano, MD
University of California Davis Comprehensive Cancer Center, Sacramento, CA

Mazyar Shadman, MD, MPH
Fred Hutchinson Cancer Cancer, Seattle, WA

Philippe Armand, MD, PhD
Dana-Farber Cancer Institute, Boston, MA

Marc S. Hoffmann, MD
University of Kansas Cancer Center, Kansas City, KS

Reem Karmali, MD
Northwestern University Feinberg School of Medicine, Chicago, IL, USA


Download the meeting agenda

View Agenda


  • Advances in DLBCL/Aggressive B-Cell Lymphoma
  • Advances in Follicular Lymphoma and Mantle Cell Lymphoma
  • Updates in T-Cell Lymphoma
  • Evolving Therapies in CLL/SLL

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.